Index NDX, S&P 500
P/E 67.48
EPS (ttm) 5.54
Insider Own 0.69%
Shs Outstand 352.30M
Perf Week -0.05%
Market Cap 132.56B
Forward P/E 50.82
EPS next Y 7.36
Insider Trans -11.68%
Shs Float 351.99M
Perf Month -4.53%
Income 1.99B
PEG 5.37
EPS next Q 1.54
Inst Own 85.40%
Short Float 0.97%
Perf Quarter 1.06%
Sales 7.32B
P/S 18.11
EPS this Y 9.95%
Inst Trans -0.44%
Short Ratio 2.11
Perf Half Y 37.20%
Book/sh 39.36
P/B 9.50
EPS next Y 17.21%
ROA 13.76%
Short Interest 3.41M
Perf Year 24.47%
Cash/sh 13.54
P/C 27.62
EPS next 5Y 12.56%
ROE 15.79%
52W Range 254.85 - 403.76
Perf YTD 10.86%
Dividend Est. -
P/FCF 648.21
EPS past 5Y 9.71%
ROI 14.24%
52W High -7.37%
Beta 1.39
Dividend TTM -
Quick Ratio 4.61
Sales past 5Y 14.41%
Gross Margin 66.41%
52W Low 46.75%
ATR (14) 10.06
Dividend Ex-Date -
Current Ratio 5.55
EPS Y/Y TTM 52.08%
Oper. Margin 25.26%
RSI (14) 43.27
Volatility 3.16% 2.45%
Employees 13676
Debt/Eq 0.00
Sales Y/Y TTM 13.81%
Profit Margin 27.16%
Recom 2.00
Target Price 424.71
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 51.45%
Payout 0.00%
Rel Volume 0.49
Prev Close 377.08
Sales Surprise 1.09%
EPS Surprise 5.89%
Sales Q/Q 11.46%
Earnings Apr 18 AMC
Avg Volume 1.62M
Price 373.98
SMA20 -2.65%
SMA50 -3.16%
SMA200 12.21%
Trades
Volume 648,660
Change -0.82%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-17-23 Initiated
HSBC Securities
Buy
$318
Jul-19-23 Initiated
Robert W. Baird
Outperform
$377
Apr-19-23 Reiterated
Wells Fargo
Overweight
$289 → $310
Apr-19-23 Reiterated
Truist
Buy
$300 → $325
Apr-19-23 Reiterated
Stifel
Buy
$285 → $315
Apr-19-23 Reiterated
RBC Capital Mkts
Outperform
$305 → $309
Apr-19-23 Reiterated
Raymond James
Outperform
$270 → $323
Apr-19-23 Reiterated
Morgan Stanley
Equal-Weight
$265 → $285
Apr-19-23 Reiterated
JP Morgan
Overweight
$250 → $335
Apr-19-23 Reiterated
Evercore ISI
In-line
$240 → $270
Apr-19-23 Reiterated
Citigroup
Buy
$305 → $317
Apr-19-23 Reiterated
BTIG Research
Buy
$284 → $313
Apr-19-23 Reiterated
BofA Securities
Buy
$300 → $315
Mar-29-23 Initiated
UBS
Neutral
$278
Mar-23-23 Initiated
William Blair
Outperform
Oct-18-22 Initiated
Barclays
Overweight
$235
Oct-13-22 Initiated
Mizuho
Neutral
$215
Oct-12-22 Initiated
Jefferies
Hold
$210
Apr-13-22 Initiated
Truist
Buy
$360
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$315
Show Previous Ratings
Today 02:26PM
11:16AM
Apr-23-24 11:07AM
Apr-22-24 09:00AM
Apr-20-24 01:03AM
04:13PM
Loading…
Apr-19-24 04:13PM
(Investor's Business Daily)
10:55AM
10:08AM
(Investor's Business Daily)
08:15AM
07:59AM
07:00AM
(Thomson Reuters StreetEvents)
07:00AM
03:08AM
Apr-18-24 09:46PM
09:15PM
08:53PM
Loading…
08:53PM
06:00PM
05:15PM
04:53PM
(Investor's Business Daily)
04:52PM
04:17PM
(Investor's Business Daily)
04:05PM
Apr-17-24 05:00PM
08:32AM
Apr-16-24 02:04PM
09:30AM
Apr-15-24 09:19AM
Apr-14-24 09:30AM
Apr-12-24 06:30AM
Apr-11-24 02:55PM
10:00AM
Loading…
10:00AM
Apr-10-24 05:30PM
09:21AM
09:00AM
04:35AM
Apr-09-24 06:00PM
Apr-04-24 10:52AM
10:30AM
Apr-03-24 06:00PM
Apr-02-24 07:45AM
(Investor's Business Daily)
07:04AM
Apr-01-24 02:37PM
12:10PM
06:22AM
04:30AM
Mar-31-24 07:45AM
Mar-30-24 07:18AM
Mar-29-24 09:00AM
Mar-28-24 02:36PM
08:00AM
Mar-27-24 05:50PM
Mar-26-24 10:42AM
09:30AM
Mar-25-24 06:00PM
09:53AM
Mar-22-24 02:59PM
09:46AM
Mar-21-24 08:45AM
05:06AM
Mar-20-24 09:15AM
Mar-19-24 05:50PM
02:24PM
Mar-18-24 04:30PM
09:00AM
05:42AM
Mar-15-24 04:11PM
(Investor's Business Daily)
12:17PM
(Associated Press Finance)
10:42AM
(Investor's Business Daily)
10:09AM
09:41AM
Mar-14-24 05:16PM
(Investor's Business Daily)
04:30PM
09:39AM
Mar-13-24 05:50PM
Mar-12-24 03:00PM
Mar-09-24 02:11PM
08:03AM
Mar-06-24 01:31PM
11:56AM
09:00AM
07:11AM
Mar-05-24 06:05PM
Mar-04-24 05:50PM
Mar-03-24 10:15AM
Mar-02-24 12:42AM
Feb-29-24 04:08PM
Feb-27-24 05:50PM
Feb-26-24 04:54PM
01:43AM
Feb-25-24 02:10PM
08:35AM
Feb-23-24 09:30AM
09:00AM
Feb-22-24 11:30AM
06:45AM
Feb-21-24 05:50PM
04:40PM
09:12AM
Feb-19-24 11:28AM
Feb-18-24 04:33PM
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Option Exercise 180.27 5,318 958,650 3,116 Apr 24 01:18 PM LEVY ALAN J Director Apr 23 '24 Option Exercise 154.24 2,000 308,473 27,319 Apr 24 02:22 PM Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Sale 370.66 5,318 1,971,160 298 Apr 24 01:18 PM LEVY ALAN J Director Apr 23 '24 Sale 370.70 2,000 741,398 25,319 Apr 24 02:22 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Option Exercise 59.23 1,224 72,495 722 Mar 18 02:35 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Sale 397.07 5,041 2,001,630 110 Mar 18 02:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Option Exercise 243.03 329 79,956 5,627 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Sale 390.16 329 128,363 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 11 '24 Sale 390.16 196 76,471 1,058 Mar 11 04:43 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Option Exercise 297.63 14,728 4,383,438 18,224 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Sale 393.80 20,296 7,992,510 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 08 '24 Sale 392.02 196 76,836 1,254 Mar 11 04:43 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 07 '24 Sale 393.30 196 77,087 1,450 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 06 '24 Sale 386.76 196 75,805 1,646 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 05 '24 Sale 400.00 196 78,400 1,842 Mar 07 05:17 PM Curet Myriam EVP & Chief Medical Officer Mar 01 '24 Sale 383.48 1,605 615,485 298 Mar 01 06:11 PM Curet Myriam EVP & Chief Medical Officer Feb 29 '24 Option Exercise 0.00 3,256 0 3,045 Feb 29 05:00 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 29 '24 Option Exercise 0.00 3,676 0 11,772 Feb 29 05:16 PM Rosa David J. President Feb 29 '24 Option Exercise 0.00 3,757 0 218,555 Feb 29 01:18 PM Widman Fredrik VP Corporate Controller Feb 29 '24 Option Exercise 0.00 1,317 0 4,094 Feb 29 01:04 PM Samath Jamie Chief Financial Officer Feb 29 '24 Option Exercise 0.00 2,006 0 9,139 Feb 29 07:48 PM GUTHART GARY S CEO Feb 29 '24 Option Exercise 0.00 6,370 0 16,629 Mar 01 01:01 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 29 '24 Option Exercise 0.00 1,843 0 2,483 Feb 29 07:38 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 29 '24 Option Exercise 0.00 2,201 0 23,824 Feb 29 06:56 PM Miller Brian Edward EVP & Chief Digital Officer Feb 29 '24 Option Exercise 0.00 2,817 0 13,028 Feb 29 07:26 PM MOHR MARSHALL Executive VP Global Business S Feb 29 '24 Option Exercise 0.00 3,256 0 50,150 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Option Exercise 142.35 129,810 18,478,437 58,397 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Sale 385.08 108,790 41,893,066 26,877 Feb 29 07:17 PM Curet Myriam EVP & Chief Medical Officer Feb 27 '24 Sale 386.46 843 325,786 298 Feb 27 03:58 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 26 '24 Option Exercise 0.00 1,587 0 9,597 Feb 27 06:34 PM GUTHART GARY S CEO Feb 26 '24 Option Exercise 0.00 3,030 0 13,754 Feb 26 07:38 PM Samath Jamie Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,284 0 8,197 Feb 27 03:26 PM Rosa David J. President Feb 26 '24 Option Exercise 0.00 1,710 0 216,807 Feb 27 03:19 PM MOHR MARSHALL Executive VP Global Business S Feb 26 '24 Option Exercise 0.00 1,710 0 27,744 Feb 27 03:35 PM Miller Brian Edward EVP & Chief Digital Officer Feb 26 '24 Option Exercise 0.00 1,650 0 11,432 Feb 27 03:49 PM Widman Fredrik VP Corporate Controller Feb 26 '24 Option Exercise 0.00 609 0 3,298 Feb 27 01:19 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 26 '24 Option Exercise 0.00 1,284 0 22,649 Feb 26 01:35 PM Curet Myriam EVP & Chief Medical Officer Feb 26 '24 Option Exercise 0.00 1,710 0 2,008 Feb 27 03:58 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 26 '24 Option Exercise 0.00 855 0 1,564 Feb 27 04:16 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 16 '24 Sale 378.29 32 12,105 709 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 15 '24 Sale 382.03 30 11,461 741 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 14 '24 Sale 380.09 30 11,403 771 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 13 '24 Sale 375.50 30 11,265 801 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 12 '24 Sale 386.09 481 185,709 298 Feb 13 12:29 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 12 '24 Sale 386.09 30 11,583 831 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 10 '24 Option Exercise 0.00 838 0 1,136 Feb 13 12:29 PM Widman Fredrik VP Corporate Controller Feb 10 '24 Option Exercise 0.00 568 0 2,911 Feb 12 02:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 10 '24 Option Exercise 0.00 958 0 8,326 Feb 12 02:04 PM GUTHART GARY S CEO Feb 10 '24 Option Exercise 0.00 2,634 0 12,059 Feb 12 03:38 PM Samath Jamie Chief Financial Officer Feb 10 '24 Option Exercise 0.00 1,078 0 7,314 Feb 12 03:29 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 10 '24 Option Exercise 0.00 1,078 0 21,703 Feb 12 01:55 PM MOHR MARSHALL Executive VP Global Business S Feb 10 '24 Option Exercise 0.00 2,873 0 27,119 Feb 12 03:21 PM Miller Brian Edward EVP & Chief Digital Officer Feb 10 '24 Option Exercise 0.00 1,317 0 10,269 Feb 12 04:23 PM Brosius Mark See Remarks Feb 10 '24 Option Exercise 0.00 838 0 1,286 Feb 12 04:23 PM Rosa David J. President Feb 10 '24 Option Exercise 0.00 1,437 0 215,826 Feb 12 04:54 PM LOEB GARY General Counsel Feb 10 '24 Option Exercise 0.00 315 0 2,024 Feb 12 08:57 PM Rosa David J. President Feb 07 '24 Option Exercise 52.37 140,850 7,375,967 230,089 Feb 08 02:06 PM Rosa David J. President Feb 07 '24 Sale 389.28 80,710 31,418,468 163,399 Feb 08 02:06 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 01 '24 Sale 378.41 39 14,758 448 Feb 05 05:15 PM GUTHART GARY S CEO Jan 29 '24 Option Exercise 51.02 33,750 1,721,776 33,750 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 376.06 24,325 9,147,669 9,425 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 374.41 4,960 1,857,074 27,360 Jan 30 04:28 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Option Exercise 179.67 4,318 775,816 3,007 Jan 29 05:32 PM Johnson Amal M Director Jan 26 '24 Option Exercise 56.97 6,696 381,501 18,402 Jan 29 05:25 PM LEVY ALAN J Director Jan 26 '24 Option Exercise 92.79 2,000 185,578 27,247 Jan 29 05:28 PM Johnson Amal M Director Jan 26 '24 Sale 370.08 6,696 2,478,032 11,706 Jan 29 05:25 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Sale 370.15 4,318 1,598,298 189 Jan 29 05:32 PM LEVY ALAN J Director Jan 26 '24 Sale 370.20 2,000 740,405 25,319 Jan 29 05:28 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Option Exercise 173.01 8,819 1,525,799 4,689 Nov 17 03:00 PM Johnson Amal M Director Nov 16 '23 Option Exercise 41.26 9,567 394,713 21,273 Nov 17 03:11 PM Johnson Amal M Director Nov 16 '23 Sale 300.00 9,567 2,870,100 11,706 Nov 17 03:11 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Sale 300.00 8,819 2,645,700 189 Nov 17 03:00 PM DeSantis Robert EVP & Chief Strategy & Corp Op Nov 14 '23 Option Exercise 244.58 867 212,054 7,856 Nov 15 06:45 PM LEVY ALAN J Director Nov 14 '23 Option Exercise 90.49 2,000 180,989 27,319 Nov 15 06:44 PM LEVY ALAN J Director Nov 14 '23 Sale 290.00 2,000 580,000 25,319 Nov 15 06:44 PM DeSantis Robert EVP & Chief Strategy & Corp Op Nov 14 '23 Sale 290.00 867 251,430 7,259 Nov 15 06:45 PM GUTHART GARY S CEO Oct 26 '23 Option Exercise 49.34 33,750 1,665,336 50,936 Oct 26 07:51 PM GUTHART GARY S CEO Oct 26 '23 Sale 260.11 27,385 7,123,030 23,551 Oct 26 07:51 PM DeSantis Robert EVP & Chief Strategy & Corp Op Oct 24 '23 Option Exercise 194.12 1,110 215,468 7,823 Oct 25 04:30 PM GUTHART GARY S CEO Oct 24 '23 Sale 271.93 4,960 1,348,773 29,840 Oct 26 07:51 PM DeSantis Robert EVP & Chief Strategy & Corp Op Oct 24 '23 Sale 273.49 1,110 303,574 7,259 Oct 25 04:30 PM LOEB GARY General Counsel Oct 10 '23 Option Exercise 0.00 2,613 0 2,613 Oct 12 05:18 PM Ladd Amy L Director Sep 14 '23 Sale 305.68 500 152,840 702 Sep 15 04:39 PM LEVY ALAN J Director Aug 07 '23 Option Exercise 86.04 2,000 172,074 26,854 Aug 08 05:21 PM LEVY ALAN J Director Aug 07 '23 Sale 310.00 2,000 620,000 25,319 Aug 08 05:21 PM GUTHART GARY S CEO Jul 31 '23 Sale 325.89 4,960 1,616,414 32,320 Aug 01 04:47 PM GUTHART GARY S CEO Jul 28 '23 Option Exercise 42.64 67,500 2,877,977 67,500 Aug 01 04:47 PM GUTHART GARY S CEO Jul 28 '23 Sale 326.76 50,314 16,440,733 17,186 Aug 01 04:47 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 25 '23 Option Exercise 232.81 2,535 590,185 7,853 Jul 26 05:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Jul 25 '23 Sale 323.26 2,535 819,460 7,259 Jul 26 05:35 PM DeSantis Robert EVP & Chief Product Officer Jun 14 '23 Option Exercise 290.33 2,443 709,276 9,702 Jun 15 05:04 PM MOHR MARSHALL Executive VP Global Business S Jun 14 '23 Option Exercise 59.46 11,250 668,950 35,386 Jun 15 05:29 PM BARRATT CRAIG H Director Jun 14 '23 Option Exercise 41.26 1,567 64,651 1,567 Jun 15 05:16 PM MOHR MARSHALL Executive VP Global Business S Jun 14 '23 Sale 325.00 11,250 3,656,250 24,136 Jun 15 05:29 PM DeSantis Robert EVP & Chief Product Officer Jun 14 '23 Sale 325.00 2,443 793,975 7,259 Jun 15 05:04 PM BARRATT CRAIG H Director Jun 14 '23 Sale 322.78 1,567 505,796 0 Jun 15 05:16 PM DeSantis Robert EVP & Chief Product Officer May 11 '23 Option Exercise 0.00 363 0 7,428 May 12 05:23 PM BARRATT CRAIG H Director May 01 '23 Option Exercise 41.26 2,000 82,516 2,000 May 02 05:15 PM BARRATT CRAIG H Director May 01 '23 Sale 306.00 2,000 612,000 0 May 02 05:15 PM RUBASH MARK J Director Apr 28 '23 Option Exercise 187.36 7,323 1,372,015 17,153 May 01 04:59 PM
Index -
P/E -
EPS (ttm) -62.55
Insider Own 4.63%
Shs Outstand 1.63M
Perf Week 10.33%
Market Cap 5.46M
Forward P/E 3.35
EPS next Y 0.99
Insider Trans 0.00%
Shs Float 1.58M
Perf Month 5.08%
Income -101.35M
PEG -
EPS next Q -
Inst Own 36.58%
Short Float 5.68%
Perf Quarter -19.60%
Sales 264.74M
P/S 0.02
EPS this Y -
Inst Trans -50.01%
Short Ratio 0.63
Perf Half Y -42.20%
Book/sh -45.01
P/B -
EPS next Y -
ROA -30.25%
Short Interest 0.09M
Perf Year -94.03%
Cash/sh 23.13
P/C 0.14
EPS next 5Y 12.00%
ROE -130.19%
52W Range 2.29 - 68.54
Perf YTD -42.66%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -62.17%
52W High -95.17%
Beta 1.96
Dividend TTM -
Quick Ratio 1.35
Sales past 5Y -5.02%
Gross Margin 33.96%
52W Low 44.54%
ATR (14) 0.24
Dividend Ex-Date -
Current Ratio 1.69
EPS Y/Y TTM -190.13%
Oper. Margin -5.20%
RSI (14) 55.44
Volatility 5.83% 7.42%
Employees 644
Debt/Eq -
Sales Y/Y TTM -7.05%
Profit Margin -38.28%
Recom 3.00
Target Price 23.77
Option/Short No / Yes
LT Debt/Eq -
EPS Q/Q -1644.68%
Payout -
Rel Volume 0.10
Prev Close 3.33
Sales Surprise -4.59%
EPS Surprise -
Sales Q/Q -32.02%
Earnings Jan 09 AMC
Avg Volume 143.28K
Price 3.31
SMA20 6.26%
SMA50 8.98%
SMA200 -60.13%
Trades
Volume 11,321
Change -0.60%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-16-22 Upgrade
Craig Hallum
Hold → Buy
$8 → $10
Dec-22-21 Downgrade
Craig Hallum
Buy → Hold
$14 → $10
Sep-24-21 Reiterated
Craig Hallum
Buy
$16 → $14
Jun-25-21 Reiterated
Craig Hallum
Buy
$15 → $16
Dec-18-20 Downgrade
JP Morgan
Neutral → Underweight
$10 → $11
Apr-17-20 Upgrade
Jefferies
Hold → Buy
$8.25
Mar-05-20 Reiterated
Craig Hallum
Buy
$14 → $13
Dec-20-19 Reiterated
Craig Hallum
Buy
$16 → $14
Dec-20-19 Downgrade
First Analysis Sec
Outperform → Neutral
$17 → $12
Jun-28-19 Upgrade
Northland Capital
Market Perform → Outperform
May-29-19 Downgrade
Goldman
Neutral → Sell
May-01-19 Reiterated
Craig Hallum
Buy
$17 → $16
Mar-25-19 Downgrade
JP Morgan
Overweight → Neutral
$17
Jan-25-19 Upgrade
JP Morgan
Neutral → Overweight
Dec-21-18 Upgrade
Craig Hallum
Hold → Buy
$25 → $17
Dec-14-18 Reiterated
B. Riley FBR
Buy
$32 → $28
Dec-11-18 Downgrade
Northland Capital
Outperform → Market Perform
Dec-11-18 Downgrade
First Analysis Sec
Strong Buy → Outperform
$29 → $22
Nov-27-18 Initiated
Goldman
Neutral
$20
Oct-15-18 Initiated
Jefferies
Hold
$22
Show Previous Ratings
Feb-27-24 09:22PM
Jan-10-24 08:27AM
07:10AM
(Thomson Reuters StreetEvents)
Jan-09-24 09:51PM
04:51PM
(Associated Press Finance)
04:30PM
Loading…
04:30PM
Jan-08-24 06:30AM
Dec-26-23 04:30PM
Dec-18-23 04:31PM
Oct-17-23 06:33AM
Oct-06-23 05:00PM
12:12PM
(Associated Press Finance)
08:13AM
06:43AM
(Thomson Reuters StreetEvents)
Oct-05-23 05:50PM
04:42PM
Loading…
04:42PM
(Associated Press Finance)
04:30PM
Sep-25-23 04:00PM
Aug-28-23 04:30PM
Jul-13-23 12:08PM
Jul-11-23 07:20AM
(Thomson Reuters StreetEvents) -11.80%
Jul-10-23 05:35PM
04:23PM
04:05PM
Jun-26-23 05:00PM
May-11-23 06:00AM
May-04-23 07:45AM
Apr-29-23 08:01AM
Apr-28-23 08:33AM
(Thomson Reuters StreetEvents) +7.17%
Apr-27-23 05:19PM
04:05PM
Loading…
04:05PM
Apr-13-23 07:45AM
Apr-05-23 09:15AM
Mar-09-23 06:17AM
Jan-27-23 08:00AM
07:45AM
Jan-20-23 08:50AM
Jan-03-23 04:05PM
Dec-30-22 08:50AM
Dec-29-22 08:30AM
Dec-20-22 04:05PM
Dec-06-22 07:45AM
Dec-02-22 04:05PM
Nov-23-22 08:29AM
Oct-27-22 08:18AM
Oct-26-22 11:05AM
Oct-05-22 12:21PM
Sep-30-22 06:06AM
Sep-22-22 05:25PM
05:00PM
(Thomson Reuters StreetEvents)
04:05PM
03:14PM
Sep-07-22 04:05PM
Sep-02-22 06:59PM
Aug-26-22 05:09PM
04:15PM
Aug-01-22 12:30PM
Jul-28-22 04:05PM
Jul-20-22 07:45AM
Jun-30-22 06:10AM
Jun-24-22 11:33AM
Jun-23-22 05:25PM
04:31PM
04:05PM
11:40AM
Jun-22-22 07:45AM
Jun-21-22 05:00PM
07:45AM
Jun-20-22 12:00PM
Jun-09-22 07:45AM
May-30-22 07:38AM
May-26-22 11:40AM
May-23-22 04:05PM
May-17-22 07:45AM
May-11-22 07:00AM
May-05-22 07:45AM
May-03-22 02:26PM
07:45AM
May-02-22 06:30AM
Apr-29-22 11:37AM
Apr-28-22 05:55PM
04:05PM
Apr-21-22 06:00AM
Apr-14-22 07:45AM
Apr-05-22 11:40AM
Mar-28-22 05:32PM
Mar-08-22 07:45AM
Mar-03-22 07:45AM
Feb-22-22 07:00AM
Feb-18-22 11:40AM
Feb-10-22 10:00AM
Feb-07-22 08:54AM
Jan-27-22 04:05PM
Jan-05-22 07:45AM
Jan-04-22 07:45AM
Dec-30-21 04:10PM
Dec-23-21 04:22AM
Dec-22-21 11:06AM
09:50AM
Dec-21-21 08:30PM
CalAmp Corp. engages in the provision of wireless access and computer technologies. It operates through the Software and Subscription Services, and Telematics Products segments. The Software and Subscription Services segment offers solutions consisting of telematics devices bundled with cloud-based application enablement and telematics services. The Telematics Products segment focuses on telematics products for the broader connected vehicle and industrial IoT marketplace. The company was founded in 1981 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cohenour Jason Director Mar 05 '24 Option Exercise 0.00 7,824 0 10,962 Mar 07 07:41 PM Scott Richard M. Chief Legal Officer, Secretary Nov 05 '23 Option Exercise 0.00 3,167 0 53,090 Nov 07 02:48 PM Carson Brennen Chief Revenue Officer Sep 05 '23 Option Exercise 0.00 4,167 0 15,951 Sep 07 12:37 PM Scott Richard M. Chief Legal Officer, Secretary Jul 28 '23 Option Exercise 0.00 3,167 0 51,494 Jul 31 05:01 PM Van Berkel Monica Chief People Officer Jul 24 '23 Option Exercise 0.00 5,540 0 106,885 Jul 25 12:43 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite